Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Multivalent Vaccines for Rabies Virus and Coronaviruses

Краткое содержание

The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Thomas Jefferson University, located in Philadelphia, Pennsylvania to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.